Patent · US Active

Bupropion hydrobromide polymorphs

US8604085B2 · kind B2 · utility

0Cited by
16References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 2012
Grant dateDec 10, 2013
Priority date—
Expiry dateOct 17, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Polymorphous and amorphous forms of bupropion hydrobromide are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.